Table 2.
VZV, EBV, and CMV seroprevalence.
| VZV (n = 129) | EBV (n = 74) | CMV (n = 80) | ||
|---|---|---|---|---|
| Seroprevalence | 97.6% (n = 126) | 86.5% (n = 64) | 30% (n = 24) | p = 0.00001 |
| <60 years | 98% (n = 109) | 84% (n = 54) | 25.75% (n = 17) | |
| >60 years | 94% (n = 17) | 100% (n = 10) | 50% (n = 7) |